SR3335, RORα partial inverse agonist, 5mg, CAS# 293753-05-6

SR3335, RORα partial inverse agonist, 5mg, CAS# 293753-05-6

Galunisertib, TGFß receptor 1 inhibitor / Cancer immunotherapeutic, 25mg, CAS# 700874-72-2

Galunisertib, TGFß receptor 1 inhibitor / Cancer immunotherapeutic, 25mg, CAS# 700874-72-2

Serodolin, ß-Arrestin-biased 5-HT7 antagonist, 5mg, CAS# 1814929-81-1

$80.00
1-(5-(4-(4-Fluorophenyl)piperazin-1-yl)pentyl)-1H-benzo[d]imidazole-2(3H)-one Purity: >98% by HPLC NMR (Conforms) Store -20°C Ship RT (1 per EA )

Manufacturer: Focus Biomolecules

SKU
10-4086-5mg-EA
Serodolin, ß-Arrestin-biased 5-HT7 antagonist, 5mg, CAS# 1814929-81-1 is available to buy in increments of 1

Product Details

Download Details and Specifications

Serodolin is a potent dual antagonist of the serotonin receptors 5-HT7 (Ki = 6.2 nM; IC50 = 5.7 nM cAMP response) and 5-HT2A (Ki = 19 nM; IC50 = 110 nM IP1 response) with significant selectivity over 5-HT1A and 5-HT6.1 Serodolin has recently been found to act as a ß-arrestin-biased inverse agonist on Gs signaling while inducing ERK activation requiring c-SRS activation, a unique pharmacological profile among 5-HT7 ligands.2 It decreased hyperalgesia and pain sensation in response to inflammatory, thermal, and mechanical stimulation in a mouse model demonstrating the therapeutic potential of a ß-arrestin-biased ligand for pain relief. Blood-brain barrier permeable.

CAS Number: 1814929-81-1

Manufacturer Part Number/SKU: 10-4086-5mg-EA

Tags: Focus Biomolecules